Compound | Half maximum inhibitory concentration (IC50 μM) | ||||||
---|---|---|---|---|---|---|---|
xL3 motility | L4 motility | L4 development | |||||
24 h | 48 h | 72 h | 24 h | 48 h | 72 h | 7 days | |
a-15 | – | – | 55.63 ± 0.18 | – | – | 26.31a | 3.97 ± 0.35 |
a-17 | – | – | 51.60 ± 1.41 | – | – | 15.58a | 3.42 ± 0.50 |
Tolfenpyrad | 2.98 ± 0.50 | 3.85 ± 1.33 | 3.05 ± 0.47 | 0.12 ± 0.07 | 0.06 ± 0.02 | 0.03 ± 0.02 | 0.08 ± 0.01 |
Tebufenpyrad | na | na | na | > 100 | > 100 | > 100 | 6.70a |